185 related articles for article (PubMed ID: 30131438)
1. Primary Ovarian Insufficiency and Adolescent Vaccination.
Naleway AL; Mittendorf KF; Irving SA; Henninger ML; Crane B; Smith N; Daley MF; Gee J
Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30131438
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS).
Patricia Wodi A; Marquez P; Mba-Jonas A; Barash F; Nguon K; Moro PL
Vaccine; 2023 Feb; 41(9):1616-1622. PubMed ID: 36732165
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study.
Rivera L; Schwarz TF; Kim KH; Kim YK; Behre U; Cha SH; Jo DS; Lee J; Lee JS; Cheuvart B; Jastorff A; Van der Wielen M
Vaccine; 2018 Jul; 36(31):4750-4758. PubMed ID: 29960800
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial.
Wheeler CM; Harvey BM; Pichichero ME; Simon MW; Combs SP; Blatter MM; Marshall GS; Catteau G; Dobbelaere K; Descamps D; Dubin G; Schuind A
Pediatr Infect Dis J; 2011 Dec; 30(12):e225-34. PubMed ID: 21817954
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States.
Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS
J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327
[TBL] [Abstract][Full Text] [Related]
6. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ
Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346
[TBL] [Abstract][Full Text] [Related]
7. A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016.
Irving SA; Groom HC; Dandamudi P; Daley MF; Donahue JG; Gee J; Hechter R; Jackson LA; Klein NP; Liles E; Myers TR; Stokley S
Vaccine; 2022 Feb; 40(9):1246-1252. PubMed ID: 35125221
[TBL] [Abstract][Full Text] [Related]
8. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial.
Rivera L; Chanthavanich P; Põder A; Suryakiran PV; Jastorff A; Van der Wielen M
Vaccine; 2018 Jun; 36(27):3967-3975. PubMed ID: 29789243
[TBL] [Abstract][Full Text] [Related]
9. Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System.
Datwani H; Moro PL; Harrington T; Broder KR
Vaccine; 2015 Jun; 33(27):3110-3. PubMed ID: 25976546
[TBL] [Abstract][Full Text] [Related]
10. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.
Arguedas A; Soley C; Loaiza C; Rincon G; Guevara S; Perez A; Porras W; Alvarado O; Aguilar L; Abdelnour A; Grunwald U; Bedell L; Anemona A; Dull PM
Vaccine; 2010 Apr; 28(18):3171-9. PubMed ID: 20189491
[TBL] [Abstract][Full Text] [Related]
12. Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination and Autism Spectrum Disorder.
Becerra-Culqui TA; Getahun D; Chiu V; Sy LS; Tseng HF
Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30104424
[TBL] [Abstract][Full Text] [Related]
13. The Association of Prenatal Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccination With Attention-Deficit/Hyperactivity Disorder.
Becerra-Culqui TA; Getahun D; Chiu V; Sy LS; Tseng HF
Am J Epidemiol; 2020 Oct; 189(10):1163-1172. PubMed ID: 32378703
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal Conjugate and Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccination Among HIV-infected Youth.
Setse RW; Siberry GK; Moss WJ; Wheeling J; Bohannon BA; Dominguez KL;
Pediatr Infect Dis J; 2016 May; 35(5):e152-7. PubMed ID: 26855409
[TBL] [Abstract][Full Text] [Related]
15. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
[TBL] [Abstract][Full Text] [Related]
16. Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine.
Baxter R; Hansen J; Timbol J; Pool V; Greenberg DP; Johnson DR; Decker MD
Hum Vaccin Immunother; 2016 Nov; 12(11):2742-2748. PubMed ID: 27388557
[TBL] [Abstract][Full Text] [Related]
17. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
[TBL] [Abstract][Full Text] [Related]
18. Missed opportunities for adolescent vaccination, 2006-2011.
Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA
J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™.
Leonardi M; Latiolais T; Sarpong K; Simon M; Twiggs J; Lei P; Rinderknecht S; Blatter M; Bianco V; Baine Y; Friedland LR; Baccarini C; Miller JM
Vaccine; 2015 Feb; 33(7):924-32. PubMed ID: 25305567
[TBL] [Abstract][Full Text] [Related]
20. Middle school vaccination requirements and adolescent vaccination coverage.
Bugenske E; Stokley S; Kennedy A; Dorell C
Pediatrics; 2012 Jun; 129(6):1056-63. PubMed ID: 22566425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
